GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $87,000 | -99.2% | 1,376 | -99.4% | 0.00% | -100.0% |
Q1 2020 | $10,869,000 | -7.0% | 212,748 | +44.7% | 0.03% | +23.1% |
Q4 2019 | $11,685,000 | +1466.4% | 146,996 | +856.7% | 0.03% | +1200.0% |
Q3 2019 | $746,000 | -80.3% | 15,365 | -78.6% | 0.00% | -77.8% |
Q2 2019 | $3,783,000 | +646.2% | 71,923 | +650.8% | 0.01% | +800.0% |
Q1 2019 | $507,000 | +124.3% | 9,580 | +91.6% | 0.00% | 0.0% |
Q2 2018 | $226,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |